Canada markets close in 5 hours 43 minutes

REGENXBIO Inc. (RGNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.26+0.20 (+1.25%)
As of 10:13AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
90,242
90,242
112,724
470,347
154,567
Cost of Revenue
37,213
37,213
54,545
51,833
35,714
Gross Profit
53,029
53,029
58,179
418,514
118,853
Operating Expenses
Research Development
232,266
232,266
242,453
181,437
166,294
Selling General and Administrative
88,494
88,494
85,281
79,333
63,817
Total Operating Expenses
321,157
321,157
321,055
258,534
238,086
Operating Income or Loss
-268,128
-268,128
-262,876
159,980
-119,233
Interest Expense
6,862
6,862
23,254
26,277
771
Total Other Income/Expenses Net
11,319
11,319
5,383
6,825
9,723
Income Before Tax
-263,646
-263,646
-280,405
141,247
-106,010
Income Tax Expense
-152
-152
-84
13,407
5,240
Income from Continuing Operations
-263,494
-263,494
-280,321
127,840
-111,250
Net Income
-263,494
-263,494
-280,321
127,840
-111,250
Net Income available to common shareholders
-263,494
-263,494
-280,321
127,840
-111,250
Basic EPS
-1.53
-6.02
-6.50
3.01
-2.98
Diluted EPS
-1.53
-6.02
-6.50
2.91
-2.98
Basic Average Shares
35,757
43,734
43,152
42,438
37,281
Diluted Average Shares
37,465
43,734
43,152
43,913
37,281